AMD

Study Links Digestive Health to AMD

Dysbiosis—adverse changes to the microorganisms of the GI tract—may trigger inflammatory processes that extend to the eye, researchers suggest.
09/22/2023

Antibiotic Use Frequency and Duration Linked to AMD Diagnosis

Exposure to aminoglycosides and fluoroquinolones was associated with new-onset cases. Could the gut microbiota play a role in disease pathogenesis?
09/21/2023

UV Radiation Linked with Early AMD Onset

However, the researchers were unable to document a dose response based on lifetime exposure.
09/19/2023

AMD Genetic Profile Predictive of Early GA Enlargement

ARMS2/HTRA1 is an important risk factor for identifying eyes likely to experience fast lesion progression.
09/19/2023

The Wild and Woolly World of Anti-VEGF in 2023

A once-simple treatment protocol has gotten more sophisticated—and complicated—by novel drug compounds, varied dosing regimens and sustained-release delivery methods. Here’s the current state of affairs.
09/15/2023

Subretinal Drusenoid Deposits May be Hereditary

Although relatives of patients may also be at risk of development, the strongest predictor of changes in a recent study was older age.
09/11/2023

Large Area, Fast Growth Risk Factors for MNV Exudative Progression in AMD

Studies show OCT-A helps detect and characterize lesions, which may aid earlier diagnosis and monitoring.
09/05/2023

Study Identifies Nine New AMD Risk Loci

A total of 63 were detected, in addition to the well-established CFH and ARMS2 loci, which researchers found don't have as much prediction accuracy as prior reports have concluded.
08/30/2023

AMD Prevalence High in Asian-Americans Age 40 to 60

Study shows this in Asian Medicare beneficiaries, including females between the ages of 40 and 64 with a history of diabetes or hypertension.
08/25/2023

Avoid Misdiagnosing Late-Onset Stargardt’s Disease for AMD

The use of multimodal imaging can distinguish between these two conditions.
08/24/2023

Upcoming Events

September 22-24, 2023

New Technologies & Treatments in Eye Care—Philadelphhia, PA
Location: The Westin Philadelphia
Program Chair: Paul Karpecki, OD, FAAO

Earn up to 21 CE credits (COPE approval pending)

Register here

September 27, 2023

Showcasing Inflammation and IOP Control
Location: Canaletto, Las Vegas, NV
Presenters: Derek Cunningham, OD, and Jessica Steen, OD
Presentation: 7:00 PM PT

Sponsored by Bausch + Lomb

Register here

October 3, 2023

Addressing a Major Gap in the Treatment of Dry Eye Disease
Location: Virtual
Presenters: Damon Dierker, OD, and Jennifer Loh, MD
Webinar: 8:00pm ET

Sponsored by Bausch + Lomb

Register here